INT171522

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.23
First Reported 2002
Last Reported 2002
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.10
Pain Relevance 0.03

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (RPL6) structural constituent of ribosome (RPL6) ribosome (RPL6)
RNA binding (RPL6) intracellular (RPL6) translation (RPL6)
RPL6 (Homo sapiens)
Pain Link Frequency Relevance Heat
psoriasis 1 50.08 Quite High
Inflammation 1 37.76 Quite Low
headache 1 31.20 Quite Low
Potency 3 9.00 Low Low
agonist 5 5.00 Very Low Very Low Very Low
antagonist 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 1 51.44 Quite High
Psoriasis 1 50.08 Quite High
Sarcoma 1 48.32 Quite Low
INFLAMMATION 1 37.76 Quite Low
Repression 2 37.04 Quite Low
Thyroid Disease 1 33.92 Quite Low
Headache 1 31.20 Quite Low
Wrinkles 1 20.96 Low Low
Cancer 1 20.00 Low Low
Metabolic Disorder 1 18.24 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Apoferritin H and TAXREB107 were clearly inhibited by a specific set of retinoids (40–50% inhibition), to an extent which is considered to be highly significant in pathological states.
Negative_regulation (inhibited) of TAXREB107
1) Confidence 0.23 Published 2002 Journal BMC Pharmacol Section Body Doc Link PMC113761 Disease Relevance 0.10 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox